CLGN
NASDAQ · Biotechnology
Collplant Biotechnologies Lt
$0.42
+0.00 (+0.36%)
Open$0.44
Previous Close$0.42
Day High$0.44
Day Low$0.42
52W High$4.98
52W Low$0.27
Volume—
Avg Volume39.7K
Market Cap6.05M
P/E Ratio—
EPS$-0.93
SectorBiotechnology
Analyst Ratings
Strong Buy
8 analysts
Price Target
+3,981.2% upside
Current
$0.42
$0.42
Target
$17.19
$17.19
$14.35
$17.19 avg
$29.92
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.79M | 1.40M | 1.91M |
| Net Income | -13,523,509 | -6,110,325 | 134.3K |
| Profit Margin | -484.6% | -460.3% | 7.0% |
| EBITDA | -12,460,589 | -5,942,848 | 222.2K |
| Free Cash Flow | — | — | 168.1K |
| Rev Growth | +99.2% | +99.2% | +10.4% |
| Debt/Equity | — | — | 0.39 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $210.39 | -0.18% | 88.1 | 372.39B |
| AMGN | Amgen Inc | $326.31 | -2.95% | 23.0 | 179.23B |
| GILD | Gilead Sciences Inc | $129.58 | -1.88% | 17.4 | 160.50B |
| VRTX | Vertex Pharmaceuticals Inc | $436.95 | -2.99% | 26.4 | 114.32B |
| REGN | Regeneron Pharmaceuticals | $698.25 | -2.05% | 16.7 | 73.89B |
| ALNY | Alnylam Pharmaceuticals Inc | $286.98 | -2.20% | 66.6 | 38.43B |